Literature DB >> 11896035

Phosphorylation of the regulatory light chains of myosin affects Ca2+ sensitivity of skeletal muscle contraction.

Danuta Szczesna1, Jiaju Zhao, Michelle Jones, Gang Zhi, James Stull, James D Potter.   

Abstract

The role of phosphorylation of the myosin regulatory light chains (RLC) is well established in smooth muscle contraction, but in striated (skeletal and cardiac) muscle its role is still controversial. We have studied the effects of RLC phosphorylation in reconstituted myosin and in skinned skeletal muscle fibers where Ca2+ sensitivity and the kinetics of steady-state force development were measured. Skeletal muscle myosin reconstituted with phosphorylated RLC produced a much higher Ca2+ sensitivity of thin filament-regulated ATPase activity than nonphosphorylated RLC (change in -log of the Ca2+ concentration producing half-maximal activation = approximately 0.25). The same was true for the Ca2+ sensitivity of force in skinned skeletal muscle fibers, which increased on reconstitution of the fibers with the phosphorylated RLC. In addition, we have shown that the level of endogenous RLC phosphorylation is a crucial determinant of the Ca2+ sensitivity of force development. Studies of the effects of RLC phosphorylation on the kinetics of force activation with the caged Ca2+, DM-nitrophen, showed a slight increase in the rates of force development with low statistical significance. However, an increase from 69 to 84% of the initial steady-state force was observed when nonphosphorylated RLC-reconstituted fibers were subsequently phosphorylated with exogenous myosin light chain kinase. In conclusion, our results suggest that, although Ca2+ binding to the troponin-tropomyosin complex is the primary regulator of skeletal muscle contraction, RLC play an important modulatory role in this process.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11896035     DOI: 10.1152/japplphysiol.00858.2001

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  43 in total

1.  Changes in contractile activation characteristics of rat fast and slow skeletal muscle fibres during regeneration.

Authors:  Paul Gregorevic; David R Plant; Nicole Stupka; Gordon S Lynch
Journal:  J Physiol       Date:  2004-06-04       Impact factor: 5.182

2.  MLCK-independent phosphorylation of MLC20 and its regulation by MAP kinase pathway in human bladder smooth muscle cells.

Authors:  Maoxian Deng; Wei Ding; Xuewen Min; Ying Xia
Journal:  Cytoskeleton (Hoboken)       Date:  2010-08-18

3.  The molecular effects of skeletal muscle myosin regulatory light chain phosphorylation.

Authors:  Michael J Greenberg; Tanya R Mealy; James D Watt; Michelle Jones; Danuta Szczesna-Cordary; Jeffrey R Moore
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-05-20       Impact factor: 3.619

Review 4.  Factors modulating post-activation potentiation and its effect on performance of subsequent explosive activities.

Authors:  Neale Anthony Tillin; David Bishop
Journal:  Sports Med       Date:  2009       Impact factor: 11.136

5.  Phosphorylation of myosin regulatory light chain has minimal effect on kinetics and distribution of orientations of cross bridges of rabbit skeletal muscle.

Authors:  Divya Duggal; Janhavi Nagwekar; Ryan Rich; Krishna Midde; Rafal Fudala; Ignacy Gryczynski; Julian Borejdo
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-11-27       Impact factor: 3.619

6.  The direct molecular effects of fatigue and myosin regulatory light chain phosphorylation on the actomyosin contractile apparatus.

Authors:  Michael J Greenberg; Tanya R Mealy; Michelle Jones; Danuta Szczesna-Cordary; Jeffrey R Moore
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-01-20       Impact factor: 3.619

Review 7.  Signaling to myosin regulatory light chain in sarcomeres.

Authors:  Kristine E Kamm; James T Stull
Journal:  J Biol Chem       Date:  2011-01-21       Impact factor: 5.157

Review 8.  Pseudophosphorylation of cardiac myosin regulatory light chain: a promising new tool for treatment of cardiomyopathy.

Authors:  Sunil Yadav; Danuta Szczesna-Cordary
Journal:  Biophys Rev       Date:  2017-01-25

Review 9.  Hereditary heart disease: pathophysiology, clinical presentation, and animal models of HCM, RCM, and DCM associated with mutations in cardiac myosin light chains.

Authors:  Sunil Yadav; Yoel H Sitbon; Katarzyna Kazmierczak; Danuta Szczesna-Cordary
Journal:  Pflugers Arch       Date:  2019-01-31       Impact factor: 3.657

10.  Malignant familial hypertrophic cardiomyopathy D166V mutation in the ventricular myosin regulatory light chain causes profound effects in skinned and intact papillary muscle fibers from transgenic mice.

Authors:  W Glenn L Kerrick; Katarzyna Kazmierczak; Yuanyuan Xu; Yingcai Wang; Danuta Szczesna-Cordary
Journal:  FASEB J       Date:  2008-11-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.